Over 450 Companies Enhance Market Readiness with Veeva RIM Solutions
In recent news, Veeva Systems has made significant advancements in regulatory information management (RIM) by announcing that over 450 companies, including 19 of the top 20 biopharmaceutical firms, have adopted its innovative RIM platform. This widespread adoption signals a pivotal shift in how organizations manage regulatory compliance and market readiness. Veeva RIM operates as a unified platform that enhances connectivity and collaboration with global health authorities, ultimately streamlining processes for its users.
The continuous enhancements made to Veeva RIM include strategic partnerships with key players such as Accumulus Technologies and DNAnexus. These alliances bolster Veeva's offerings by integrating with numerous health authority platforms, significantly improving operational efficiency and regulatory compliance. The Vice President of Regulatory at Veeva, Marc Gabriel, stated that by leveraging these innovations, teams can not only enhance their efficiency but also reduce cycle times significantly thanks to the improved collaboration facilitated by Veeva RIM.
Companies employing Veeva's suite of applications report considerable optimization of regulatory processes at various stages of the regulatory life cycle. For instance, more than 85 organizations have adopted Veeva Submissions Publishing, which enables continuous publishing that reduces repetitive tasks and eliminates bottlenecks. This has resulted in accelerated turnaround times and an overall shorter time to market for their products.
Francisco Nogueira, CEO of Accumulus Technologies, expressed the excitement around the strategic alliance with Veeva, stating that it will connect the Accumulus platform with Veeva RIM. This integration will enhance interoperability and ensure that the exchange of regulatory information can occur instantly with a growing network of over 70 regulatory agencies worldwide. This strategic positioning aims to empower mutual clients, ensuring that treatments reach patients more swiftly.
In a similar vein, Thomas Laur, CEO of DNAnexus, noted that the integration of DNAnexus Trusted Regulatory Spaces (TRS) with Veeva RIM introduces cutting-edge data exchange capabilities. This would enable enhanced collaboration between agencies, facilitating faster product approvals and thereby expediting market entry for crucial therapies.
Veeva RIM helps streamline global regulatory processes on a single cloud-based platform, forming an essential part of the Veeva Development Cloud. This infrastructure is pivotal for product development across various areas including clinical, quality, regulatory, and safety sectors. Life sciences companies of all sizes—from the largest biopharmaceutical firms to emerging biotech innovators—are leveraging Veeva's industry-specific cloud solutions to drive their success.
Veeva is committed to balancing the interests of all stakeholders, which include clients, employees, shareholders, and the industries it serves. As a Public Benefit Corporation, Veeva prides itself on its innovation and commitment to excellence, ensuring that its clients thrive in a competitive market.
For more information on Veeva RIM and its capabilities, interested parties can visit veeva.com/eu/RIM. The successes and trends outlined above highlight the critical role that advanced regulatory management tools play in not just surviving, but thriving in today's rapidly evolving life sciences landscape.
The continuous enhancements made to Veeva RIM include strategic partnerships with key players such as Accumulus Technologies and DNAnexus. These alliances bolster Veeva's offerings by integrating with numerous health authority platforms, significantly improving operational efficiency and regulatory compliance. The Vice President of Regulatory at Veeva, Marc Gabriel, stated that by leveraging these innovations, teams can not only enhance their efficiency but also reduce cycle times significantly thanks to the improved collaboration facilitated by Veeva RIM.
Companies employing Veeva's suite of applications report considerable optimization of regulatory processes at various stages of the regulatory life cycle. For instance, more than 85 organizations have adopted Veeva Submissions Publishing, which enables continuous publishing that reduces repetitive tasks and eliminates bottlenecks. This has resulted in accelerated turnaround times and an overall shorter time to market for their products.
Francisco Nogueira, CEO of Accumulus Technologies, expressed the excitement around the strategic alliance with Veeva, stating that it will connect the Accumulus platform with Veeva RIM. This integration will enhance interoperability and ensure that the exchange of regulatory information can occur instantly with a growing network of over 70 regulatory agencies worldwide. This strategic positioning aims to empower mutual clients, ensuring that treatments reach patients more swiftly.
In a similar vein, Thomas Laur, CEO of DNAnexus, noted that the integration of DNAnexus Trusted Regulatory Spaces (TRS) with Veeva RIM introduces cutting-edge data exchange capabilities. This would enable enhanced collaboration between agencies, facilitating faster product approvals and thereby expediting market entry for crucial therapies.
Veeva RIM helps streamline global regulatory processes on a single cloud-based platform, forming an essential part of the Veeva Development Cloud. This infrastructure is pivotal for product development across various areas including clinical, quality, regulatory, and safety sectors. Life sciences companies of all sizes—from the largest biopharmaceutical firms to emerging biotech innovators—are leveraging Veeva's industry-specific cloud solutions to drive their success.
Veeva is committed to balancing the interests of all stakeholders, which include clients, employees, shareholders, and the industries it serves. As a Public Benefit Corporation, Veeva prides itself on its innovation and commitment to excellence, ensuring that its clients thrive in a competitive market.
For more information on Veeva RIM and its capabilities, interested parties can visit veeva.com/eu/RIM. The successes and trends outlined above highlight the critical role that advanced regulatory management tools play in not just surviving, but thriving in today's rapidly evolving life sciences landscape.
Topics Business Technology）
【About Using Articles】
You can freely use the title and article content by linking to the page where the article is posted.
※ Images cannot be used.
【About Links】
Links are free to use.